Vicente Pallarés-Carratalá

Has grant

PROFESOR ASOCIADO (PDI)

Universitat Jaume I

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Vicente Pallarés-Carratalá is an Associate Professor at Universitat Jaume I, Spain. His research focuses on cardiovascular and metabolic disorders, particularly their prevalence and associations within various cohorts. He has contributed to numerous publications addressing adverse pregnancy outcomes, hypercholesterolemia, and the role of physical activity in metabolic syndrome among primary care patients.

Recent Grants

Grant: Close

Desigualdades por género derivadas de la inercia diagnóstica en los factores más prevalentes de riesgo cardiovascular: un estudio de cohortes de base poblacional (ESCARVAL GENERO)

Open Date: 2018-12-01

Close Date:

Grant: Close

Estudio LIPO-LAB

Open Date: 2016-01-01

Close Date: 2021-01-01

Grant: Close

ESTUDIO IBERICAN

Open Date: 2013-01-01

Close Date:

Grant: Close

ESTUDIO CARDIOMATEBOLICO VALENCIANO

Open Date: 2007-01-01

Close Date: 2022-01-01

Grant: Close

PREVALENCIA DE FIBRILACION AURICULAR Y FACTORES DE RIESGO ASOCIADOS EN POBLACION HIPERTENSA DE EDAD IGUAL O SUPERIOR A 65 AÑOS

Open Date: 2007-01-01

Close Date: 2012-01-01

Articles (30)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (13)

Sergio Cinza-Sanjurjo

Profesor Asociado en Ciencias de la Salud

Universidade de Santiago de Compostela

SPAIN

View details

Miguel Camafort

University of Barcelona

SPAIN

View details

Jose M. Martin-Moreno

Professor

University of Valencia

SPAIN

View details

Ferran Torres

Universitat Autònoma de Barcelona (UAB)

SPAIN

View details

Carlos Escobar

SPAIN

View details

María Ester Montes Belloso

Profesora Asociada

Universidad Europea de Madrid SLU

SPAIN

View details

Nephrologist, Head Outpatient Clinic

Central University Hospital of Asturias

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Vicente Pallarés-Carratalá

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (30)

Assessing LDL-C Levels and Lipid-Modifying Therapies in a Real-World Cohort of Patients with Atherosclerotic Cardiovascular Disease: The REALITY Study

From the Cardiovascular–Kidney–Metabolic Disorders to the Atherosclerotic Cardiovascular Diseases: Their Prevalence Rates and Independent Associations in the SIMETAP Study

Aproximación práctica del paciente con hipercolesterolemia en España. Documento de posicionamiento de SEMERGEN

Adverse Pregnancy Outcomes and Cardiovascular Disease: A Spanish Cohort

Estrategia de formación para una sociedad científica de médicos de familia: «Un enfoque integral hacia la excelencia»

Estimation of the population atributable fraction due a to excess body fat in primary care patients: IBERICAN study

Assessing LDL-C Levels and Lipid-Modifying Therapies in a Real-World Cohort of Patients with Atherosclerotic Cardiovascular Disease: The REALITY Study

Practices of low value or unnecessary practices in vascular prevention

Physical activity and metabolic syndrome in primary care patients in Spain

Primary and secondary cardiovascular prevention through life cycles in women. Consensus document of the SEC-GT CVD in Women, ACP-SEC, SEGO, AEEM, SEEN, semFYC, SEMERGEN, AEP, and AEM

Hyperuricaemia Prevalence Rates According to Their Physiochemical and Epidemiological Diagnostic Criteria and Their Associations with Cardio-Renal-Metabolic Factors: SIMETAP-HU Study

Comparison of baseline clinical characteristics among people with type 2 diabetes on second-line therapy previously added with dapagliflozin or another oral glucose-lowering drug: AGORA study

Characteristics of the phenotypes in prevalent and incident cases of heart failure in primary care: IBERICAN study

Achievement of LDL‐Cholesterol Goals in Patients Receiving LLT in Primary Care: TERESA‐AP Study

Comparison of baseline clinical characteristics among people with type 2 diabetes on second-line therapy previously added with dapagliflozin or another oral glucose-lowering drug: AGORA study

More shadows than lights in the blood pressure measurement method?

More shadows than lights in the blood pressure measurement method?

Prevalence, impact and management of hypertension-mediated organ damage in type 2 diabetes patients

Prevalence, impact and management of hypertension-mediated organ damage in type 2 diabetes patients

Multidisciplinary management of cardiovascular disease in women: Delphi consensus

Vitamin D Supplementation and Its Impact on Mortality and Cardiovascular Outcomes: Systematic Review and Meta-Analysis of 80 Randomized Clinical Trials

Heart Failure Prevalence Rates and Its Association with Other Cardiovascular Diseases and Chronic Kidney Disease: SIMETAP-HF Study

Heart Failure Prevalence Rates and Its Association with Other Cardiovascular Diseases and Chronic Kidney Disease: SIMETAP-HF Study

Fisiopatología renal y mecanismos farmacológicos de nefroprotección

Elevated pulse pressure and cardiovascular risk associated in Spanish population attended in primary care: IBERICAN study

Documento de consenso para la determinación e informe del perfil lipídico en laboratorios clínicos españoles

Cardiovascular Risk in Patients with Dyslipidemia and Their Degree of Control as Perceived by Primary Care Physicians in a Survey—TERESA-Opinion Study

Guía práctica sobre el diagnóstico y tratamiento de la hipertensión arterial en España, 2022. Sociedad Española de Hipertensión - Liga Española para la Lucha contra la Hipertensión Arterial (SEH-LELHA)

Prevalence of Hyperuricemia and Its Association with Cardiovascular Risk Factors and Subclinical Target Organ Damage

Los péptidos natriuréticos en el diagnóstico de la insuficiencia cardíaca en atención primaria

Collaborators (13)

Sergio Cinza-Sanjurjo

Miguel Camafort

Jose M. Martin-Moreno

Ferran Torres

Carlos Escobar

María Ester Montes Belloso

Josep Redon

ANNA OLIVERAS

Juan Jose Criado-Alvarez

María del Mar Castellanos

Ana Molinero Crespo

Antonio Ruiz-Garcia

Manuel Gorostidi

Make your next move.